| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.5 | 4e-05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |